EMA regular press briefing on COVID-19
Table of contents
The European Medicines Agency (EMA) is holding a press briefing to provide an update on its most recent activities in the context of the COVID-19 pandemic. The briefing will also cover the outcome of the extraordinary meeting of EMA’s human medicine committee CHMP on Friday, 28 May 2021, to discuss the paediatric indication for Comirnaty.
- Marco Cavaleri (Head of Biological Health Threats and Vaccines Strategy)
- Fergus Sweeney (Head of Clinical Studies and Manufacturing Task Force).
- Georgy Genov (Head of Pharmacovigilance)
The press briefing will be moderated by Marie-Agnes Heine (Head of Communication Department).
Virtual briefings for the media will now be organised on a regular basis, initially every two weeks. As a complement to these regular technical briefings, EMA will still organise ad-hoc press conferences as necessary and appropriate.
The press briefing will be held in English. No translations will be provided.